SG172692A1

SG172692A1 - Pan-cell surface receptor- specific therapeutics

Pan-cell surface receptor- specific therapeutics Download PDF

Info

Publication number: SG172692A1
Authority: SG; Singapore
Prior art keywords: ecd; domain; receptor; polypeptide; multimer
Prior art date: 2006-06-12

Application number

SG2011041944A

Other languages

English (en)

Inventor

H Michael Shepard

Pei Jin

Louis E Burton

Malgorzata Beryt

Original Assignee

Symphogen As

Priority date

2006-06-12

Filing date

2007-06-12

Publication date

2011-07-28

2007-06-12 Application filed by Symphogen As filed Critical Symphogen As

2011-07-28 Publication of SG172692A1 publication Critical patent/SG172692A1/en

Links

239000003814 drug Substances 0.000 title abstract description 67
102000005962 receptors Human genes 0.000 claims abstract description 285
239000003446 ligand Substances 0.000 claims abstract description 261
108010001857 Cell Surface Receptors Proteins 0.000 claims abstract description 117
238000000034 method Methods 0.000 claims abstract description 89
230000000694 effects Effects 0.000 claims abstract description 80
238000011282 treatment Methods 0.000 claims abstract description 14
108090000765 processed proteins & peptides Proteins 0.000 claims description 460
102000004196 processed proteins & peptides Human genes 0.000 claims description 451
229920001184 polypeptide Polymers 0.000 claims description 444
108020003175 receptors Proteins 0.000 claims description 285
150000001413 amino acids Chemical class 0.000 claims description 178
230000027455 binding Effects 0.000 claims description 131
238000009739 binding Methods 0.000 claims description 131
101710100969 Receptor tyrosine-protein kinase erbB-3 Proteins 0.000 claims description 128
102100029986 Receptor tyrosine-protein kinase erbB-3 Human genes 0.000 claims description 128
102000000844 Cell Surface Receptors Human genes 0.000 claims description 115
238000006471 dimerization reaction Methods 0.000 claims description 112
101710100963 Receptor tyrosine-protein kinase erbB-4 Proteins 0.000 claims description 95
102100029981 Receptor tyrosine-protein kinase erbB-4 Human genes 0.000 claims description 94
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 94
102000001301 EGF receptor Human genes 0.000 claims description 83
201000010099 disease Diseases 0.000 claims description 82
150000007523 nucleic acids Chemical class 0.000 claims description 80
102000039446 nucleic acids Human genes 0.000 claims description 77
108020004707 nucleic acids Proteins 0.000 claims description 77
210000004027 cell Anatomy 0.000 claims description 76
102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 claims description 74
101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 claims description 73
206010028980 Neoplasm Diseases 0.000 claims description 70
206010063836 Atrioventricular septal defect Diseases 0.000 claims description 58
125000000539 amino acid group Chemical group 0.000 claims description 58
238000001211 electron capture detection Methods 0.000 claims description 58
101100067974 Arabidopsis thaliana POP2 gene Proteins 0.000 claims description 48
101100118549 Homo sapiens EGFR gene Proteins 0.000 claims description 48
101100123851 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) HER1 gene Proteins 0.000 claims description 48
230000004048 modification Effects 0.000 claims description 43
238000012986 modification Methods 0.000 claims description 43
201000011510 cancer Diseases 0.000 claims description 36
102000027426 receptor tyrosine kinases Human genes 0.000 claims description 35
108091008598 receptor tyrosine kinases Proteins 0.000 claims description 35
230000000295 complement effect Effects 0.000 claims description 33
-1 HER 3 Proteins 0.000 claims description 30
101100123850 Caenorhabditis elegans her-1 gene Proteins 0.000 claims description 28
206010006187 Breast cancer Diseases 0.000 claims description 25
208000026310 Breast neoplasm Diseases 0.000 claims description 25
239000000203 mixture Substances 0.000 claims description 24
230000035772 mutation Effects 0.000 claims description 24
ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 23
238000012360 testing method Methods 0.000 claims description 22
241000894007 species Species 0.000 claims description 21
230000002209 hydrophobic effect Effects 0.000 claims description 20
230000001404 mediated effect Effects 0.000 claims description 19
ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 18
230000001447 compensatory effect Effects 0.000 claims description 17
230000004850 protein–protein interaction Effects 0.000 claims description 16
230000004927 fusion Effects 0.000 claims description 15
238000013508 migration Methods 0.000 claims description 15
150000003573 thiols Chemical class 0.000 claims description 15
239000002246 antineoplastic agent Substances 0.000 claims description 14
239000000539 dimer Substances 0.000 claims description 14
108020001507 fusion proteins Proteins 0.000 claims description 14
102000037865 fusion proteins Human genes 0.000 claims description 14
230000035755 proliferation Effects 0.000 claims description 14
208000035475 disorder Diseases 0.000 claims description 12
239000000833 heterodimer Substances 0.000 claims description 12
239000000126 substance Substances 0.000 claims description 12
239000013598 vector Substances 0.000 claims description 12
108091008794 FGF receptors Proteins 0.000 claims description 11
206010018338 Glioma Diseases 0.000 claims description 11
230000002062 proliferating effect Effects 0.000 claims description 11
210000002307 prostate Anatomy 0.000 claims description 11
108010009817 Immunoglobulin Constant Regions Proteins 0.000 claims description 10
102000009786 Immunoglobulin Constant Regions Human genes 0.000 claims description 10
102000052178 fibroblast growth factor receptor activity proteins Human genes 0.000 claims description 10
230000005012 migration Effects 0.000 claims description 10
239000008194 pharmaceutical composition Substances 0.000 claims description 10
102100022668 Pro-neuregulin-2, membrane-bound isoform Human genes 0.000 claims description 9
230000002496 gastric effect Effects 0.000 claims description 9
229940121358 tyrosine kinase inhibitor Drugs 0.000 claims description 9
239000005483 tyrosine kinase inhibitor Substances 0.000 claims description 9
208000032612 Glial tumor Diseases 0.000 claims description 8
108090000556 Neuregulin-1 Proteins 0.000 claims description 8
208000007097 Urinary Bladder Neoplasms Diseases 0.000 claims description 8
239000000470 constituent Substances 0.000 claims description 8
210000004072 lung Anatomy 0.000 claims description 8
206010005003 Bladder cancer Diseases 0.000 claims description 7
102100022659 Pro-neuregulin-3, membrane-bound isoform Human genes 0.000 claims description 7
102100033177 Vascular endothelial growth factor receptor 2 Human genes 0.000 claims description 7
230000002491 angiogenic effect Effects 0.000 claims description 7
230000002357 endometrial effect Effects 0.000 claims description 7
XGALLCVXEZPNRQ-UHFFFAOYSA-N gefitinib Chemical group C=12C=C(OCCCN3CCOCC3)C(OC)=CC2=NC=NC=1NC1=CC=C(F)C(Cl)=C1 XGALLCVXEZPNRQ-UHFFFAOYSA-N 0.000 claims description 7
208000027866 inflammatory disease Diseases 0.000 claims description 7
230000002611 ovarian Effects 0.000 claims description 7
201000005112 urinary bladder cancer Diseases 0.000 claims description 7
206010012689 Diabetic retinopathy Diseases 0.000 claims description 6
239000005411 L01XE02 - Gefitinib Substances 0.000 claims description 6
102400000058 Neuregulin-1 Human genes 0.000 claims description 6
101800000675 Neuregulin-2 Proteins 0.000 claims description 6
101800000673 Neuregulin-3 Proteins 0.000 claims description 6
101800002641 Neuregulin-4 Proteins 0.000 claims description 6
102100022658 Pro-neuregulin-4, membrane-bound isoform Human genes 0.000 claims description 6
210000004204 blood vessel Anatomy 0.000 claims description 6
238000002823 phage display Methods 0.000 claims description 6
201000001320 Atherosclerosis Diseases 0.000 claims description 5
102100023600 Fibroblast growth factor receptor 2 Human genes 0.000 claims description 5
101710182389 Fibroblast growth factor receptor 2 Proteins 0.000 claims description 5
208000031481 Pathologic Constriction Diseases 0.000 claims description 5
102100026547 Platelet-derived growth factor receptor beta Human genes 0.000 claims description 5
108060008683 Tumor Necrosis Factor Receptor Proteins 0.000 claims description 5
230000021615 conjugation Effects 0.000 claims description 5
230000003463 hyperproliferative effect Effects 0.000 claims description 5
208000037803 restenosis Diseases 0.000 claims description 5
230000008719 thickening Effects 0.000 claims description 5
102000003298 tumor necrosis factor receptor Human genes 0.000 claims description 5
102000050554 Eph Family Receptors Human genes 0.000 claims description 4
108091008815 Eph receptors Proteins 0.000 claims description 4
101800000155 Epiregulin Proteins 0.000 claims description 4
102400001329 Epiregulin Human genes 0.000 claims description 4
101800001649 Heparin-binding EGF-like growth factor Proteins 0.000 claims description 4
102400001369 Heparin-binding EGF-like growth factor Human genes 0.000 claims description 4
101000692455 Homo sapiens Platelet-derived growth factor receptor beta Proteins 0.000 claims description 4
206010020772 Hypertension Diseases 0.000 claims description 4
208000008839 Kidney Neoplasms Diseases 0.000 claims description 4
201000004681 Psoriasis Diseases 0.000 claims description 4
206010038389 Renal cancer Diseases 0.000 claims description 4
108091008874 T cell receptors Proteins 0.000 claims description 4
102000016266 T-Cell Antigen Receptors Human genes 0.000 claims description 4
229960002584 gefitinib Drugs 0.000 claims description 4
201000010982 kidney cancer Diseases 0.000 claims description 4
239000002777 nucleoside Substances 0.000 claims description 4
230000000414 obstructive effect Effects 0.000 claims description 4
BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims description 4
208000023504 respiratory system disease Diseases 0.000 claims description 4
210000000329 smooth muscle myocyte Anatomy 0.000 claims description 4
239000007787 solid Substances 0.000 claims description 4
230000036262 stenosis Effects 0.000 claims description 4
208000037804 stenosis Diseases 0.000 claims description 4
230000000699 topical effect Effects 0.000 claims description 4
208000026533 urinary bladder disease Diseases 0.000 claims description 4
108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 3
102000040650 (ribonucleotides)n+m Human genes 0.000 claims description 3
102100027844 Fibroblast growth factor receptor 4 Human genes 0.000 claims description 3
101000917134 Homo sapiens Fibroblast growth factor receptor 4 Proteins 0.000 claims description 3
241000700605 Viruses Species 0.000 claims description 3
230000000692 anti-sense effect Effects 0.000 claims description 3
229940127089 cytotoxic agent Drugs 0.000 claims description 3
239000000710 homodimer Substances 0.000 claims description 3
229940043355 kinase inhibitor Drugs 0.000 claims description 3
239000003757 phosphotransferase inhibitor Substances 0.000 claims description 3
125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 3
150000004917 tyrosine kinase inhibitor derivatives Chemical group 0.000 claims description 3
108010033760 Amphiregulin Proteins 0.000 claims description 2
229920002157 Cellulin Polymers 0.000 claims description 2
101710112752 Cytotoxin Proteins 0.000 claims description 2
239000005517 L01XE01 - Imatinib Substances 0.000 claims description 2
239000002136 L01XE07 - Lapatinib Substances 0.000 claims description 2
102000018697 Membrane Proteins Human genes 0.000 claims description 2
108010052285 Membrane Proteins Proteins 0.000 claims description 2
108020004459 Small interfering RNA Proteins 0.000 claims description 2
229960005395 cetuximab Drugs 0.000 claims description 2
231100000599 cytotoxic agent Toxicity 0.000 claims description 2
239000002619 cytotoxin Substances 0.000 claims description 2
108010011705 herstatin Proteins 0.000 claims description 2
KTUFNOKKBVMGRW-UHFFFAOYSA-N imatinib Chemical compound C1CN(C)CCN1CC1=CC=C(C(=O)NC=2C=C(NC=3N=C(C=CN=3)C=3C=NC=CC=3)C(C)=CC=2)C=C1 KTUFNOKKBVMGRW-UHFFFAOYSA-N 0.000 claims description 2
229960002411 imatinib Drugs 0.000 claims description 2
BCFGMOOMADDAQU-UHFFFAOYSA-N lapatinib Chemical compound O1C(CNCCS(=O)(=O)C)=CC=C1C1=CC=C(N=CN=C2NC=3C=C(Cl)C(OCC=4C=C(F)C=CC=4)=CC=3)C2=C1 BCFGMOOMADDAQU-UHFFFAOYSA-N 0.000 claims description 2
150000003833 nucleoside derivatives Chemical class 0.000 claims description 2
150000002894 organic compounds Chemical class 0.000 claims description 2
229960001972 panitumumab Drugs 0.000 claims description 2
229910052697 platinum Inorganic materials 0.000 claims description 2
238000001959 radiotherapy Methods 0.000 claims description 2
238000007910 systemic administration Methods 0.000 claims description 2
230000009885 systemic effect Effects 0.000 claims description 2
238000011200 topical administration Methods 0.000 claims description 2
229940094060 tykerb Drugs 0.000 claims description 2
102400000303 Collagen-like Alzheimer amyloid plaque component Human genes 0.000 claims 2
101800001122 Collagen-like Alzheimer amyloid plaque component Proteins 0.000 claims 2
102100038778 Amphiregulin Human genes 0.000 claims 1
102100026122 High affinity immunoglobulin gamma Fc receptor I Human genes 0.000 claims 1
101100066427 Homo sapiens FCGR1A gene Proteins 0.000 claims 1
108091008605 VEGF receptors Proteins 0.000 claims 1
125000002294 quinazolinyl group Chemical group N1=C(N=CC2=CC=CC=C12)* 0.000 claims 1
230000001225 therapeutic effect Effects 0.000 abstract description 15
102000006240 membrane receptors Human genes 0.000 abstract 2
235000001014 amino acid Nutrition 0.000 description 178
229940024606 amino acid Drugs 0.000 description 173
108090000623 proteins and genes Proteins 0.000 description 92
238000001990 intravenous administration Methods 0.000 description 68
102000004169 proteins and genes Human genes 0.000 description 63
235000018102 proteins Nutrition 0.000 description 60
230000003993 interaction Effects 0.000 description 53
102000001708 Protein Isoforms Human genes 0.000 description 52
108010029485 Protein Isoforms Proteins 0.000 description 52
230000014509 gene expression Effects 0.000 description 45
125000003729 nucleotide group Chemical group 0.000 description 42
101800003838 Epidermal growth factor Proteins 0.000 description 40
102400001368 Epidermal growth factor Human genes 0.000 description 40
229940116977 epidermal growth factor Drugs 0.000 description 40
VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 40
102000053602 DNA Human genes 0.000 description 37
108020004414 DNA Proteins 0.000 description 37
230000004913 activation Effects 0.000 description 37
239000002773 nucleotide Substances 0.000 description 37
108010076504 Protein Sorting Signals Proteins 0.000 description 36
125000003275 alpha amino acid group Chemical group 0.000 description 32
YOHYSYJDKVYCJI-UHFFFAOYSA-N n-[3-[[6-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide Chemical compound FC(F)(F)C1=CC=CC(NC=2N=CN=C(NC=3C=C(NC(=O)C4CC4)C=CC=3)C=2)=C1 YOHYSYJDKVYCJI-UHFFFAOYSA-N 0.000 description 31
102000052116 epidermal growth factor receptor activity proteins Human genes 0.000 description 30
108700015053 epidermal growth factor receptor activity proteins Proteins 0.000 description 30
230000011664 signaling Effects 0.000 description 27
108060006698 EGF receptor Proteins 0.000 description 26
108060003951 Immunoglobulin Proteins 0.000 description 25
102000018358 immunoglobulin Human genes 0.000 description 25
108091000080 Phosphotransferase Proteins 0.000 description 24
102000020233 phosphotransferase Human genes 0.000 description 24
230000002018 overexpression Effects 0.000 description 23
230000033115 angiogenesis Effects 0.000 description 21
230000037361 pathway Effects 0.000 description 20
230000001105 regulatory effect Effects 0.000 description 20
230000019491 signal transduction Effects 0.000 description 20
230000008520 organization Effects 0.000 description 19
230000015572 biosynthetic process Effects 0.000 description 18
102000040430 polynucleotide Human genes 0.000 description 17
108091033319 polynucleotide Proteins 0.000 description 17
239000002157 polynucleotide Substances 0.000 description 17
229920002477 rna polymer Polymers 0.000 description 17
108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 16
108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 16
102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 15
102000014413 Neuregulin Human genes 0.000 description 14
108050003475 Neuregulin Proteins 0.000 description 14
239000002253 acid Substances 0.000 description 14
230000004663 cell proliferation Effects 0.000 description 14
230000026731 phosphorylation Effects 0.000 description 14
238000006366 phosphorylation reaction Methods 0.000 description 14
239000002243 precursor Substances 0.000 description 14
150000001875 compounds Chemical class 0.000 description 13
230000006870 function Effects 0.000 description 13
125000005647 linker group Chemical group 0.000 description 13
230000008569 process Effects 0.000 description 13
230000004083 survival effect Effects 0.000 description 13
238000001193 catalytic steam reforming Methods 0.000 description 12
241000282414 Homo sapiens Species 0.000 description 11
102000004022 Protein-Tyrosine Kinases Human genes 0.000 description 11
108090000412 Protein-Tyrosine Kinases Proteins 0.000 description 11
229940022353 herceptin Drugs 0.000 description 11
230000001965 increasing effect Effects 0.000 description 11
102000009484 Vascular Endothelial Growth Factor Receptors Human genes 0.000 description 10
108010034265 Vascular Endothelial Growth Factor Receptors Proteins 0.000 description 10
230000007246 mechanism Effects 0.000 description 10
238000006467 substitution reaction Methods 0.000 description 10
238000013518 transcription Methods 0.000 description 10
230000035897 transcription Effects 0.000 description 10
102100033178 Vascular endothelial growth factor receptor 1 Human genes 0.000 description 9
230000008859 change Effects 0.000 description 9
235000018417 cysteine Nutrition 0.000 description 9
238000011161 development Methods 0.000 description 9
230000018109 developmental process Effects 0.000 description 9
239000012636 effector Substances 0.000 description 9
230000005764 inhibitory process Effects 0.000 description 9
238000003752 polymerase chain reaction Methods 0.000 description 9
150000003384 small molecules Chemical class 0.000 description 9
230000008685 targeting Effects 0.000 description 9
108020004705 Codon Proteins 0.000 description 8
101000851018 Homo sapiens Vascular endothelial growth factor receptor 1 Proteins 0.000 description 8
108091028043 Nucleic acid sequence Proteins 0.000 description 8
108091034117 Oligonucleotide Proteins 0.000 description 8
210000000481 breast Anatomy 0.000 description 8
230000012292 cell migration Effects 0.000 description 8
230000001419 dependent effect Effects 0.000 description 8
238000005734 heterodimerization reaction Methods 0.000 description 8
230000003389 potentiating effect Effects 0.000 description 8
210000001519 tissue Anatomy 0.000 description 8
230000014616 translation Effects 0.000 description 8
238000013519 translation Methods 0.000 description 8
230000004075 alteration Effects 0.000 description 7
230000004071 biological effect Effects 0.000 description 7
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 7
XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 7
230000001086 cytosolic effect Effects 0.000 description 7
238000012217 deletion Methods 0.000 description 7
230000037430 deletion Effects 0.000 description 7
229940079593 drug Drugs 0.000 description 7
239000012634 fragment Substances 0.000 description 7
238000004519 manufacturing process Methods 0.000 description 7
238000000746 purification Methods 0.000 description 7
230000004044 response Effects 0.000 description 7
239000000523 sample Substances 0.000 description 7
230000028327 secretion Effects 0.000 description 7
230000002195 synergetic effect Effects 0.000 description 7
102000018233 Fibroblast Growth Factor Human genes 0.000 description 6
108050007372 Fibroblast Growth Factor Proteins 0.000 description 6
102000043136 MAP kinase family Human genes 0.000 description 6
108091054455 MAP kinase family Proteins 0.000 description 6
108091008611 Protein Kinase B Proteins 0.000 description 6
238000003556 assay Methods 0.000 description 6
210000004899 c-terminal region Anatomy 0.000 description 6
230000024245 cell differentiation Effects 0.000 description 6
238000001514 detection method Methods 0.000 description 6
239000003623 enhancer Substances 0.000 description 6
229940126864 fibroblast growth factor Drugs 0.000 description 6
239000003102 growth factor Substances 0.000 description 6
239000001257 hydrogen Substances 0.000 description 6
229910052739 hydrogen Inorganic materials 0.000 description 6
125000001493 tyrosinyl group Chemical group [H]OC1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 6
208000005623 Carcinogenesis Diseases 0.000 description 5
102000016736 Cyclin Human genes 0.000 description 5
108050006400 Cyclin Proteins 0.000 description 5
102000004163 DNA-directed RNA polymerases Human genes 0.000 description 5
108090000626 DNA-directed RNA polymerases Proteins 0.000 description 5
101100481404 Danio rerio tie1 gene Proteins 0.000 description 5
108700039691 Genetic Promoter Regions Proteins 0.000 description 5
101000893549 Homo sapiens Growth/differentiation factor 15 Proteins 0.000 description 5
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 5
101100481406 Mus musculus Tie1 gene Proteins 0.000 description 5
108091093037 Peptide nucleic acid Proteins 0.000 description 5
102100033810 RAC-alpha serine/threonine-protein kinase Human genes 0.000 description 5
101000653754 Rattus norvegicus Sphingosine 1-phosphate receptor 5 Proteins 0.000 description 5
238000004458 analytical method Methods 0.000 description 5
230000036952 cancer formation Effects 0.000 description 5
231100000504 carcinogenesis Toxicity 0.000 description 5
230000009087 cell motility Effects 0.000 description 5
239000003795 chemical substances by application Substances 0.000 description 5
230000004186 co-expression Effects 0.000 description 5
210000001072 colon Anatomy 0.000 description 5
238000010668 complexation reaction Methods 0.000 description 5
210000005220 cytoplasmic tail Anatomy 0.000 description 5
230000003828 downregulation Effects 0.000 description 5
229940082789 erbitux Drugs 0.000 description 5
230000012010 growth Effects 0.000 description 5
210000003128 head Anatomy 0.000 description 5
230000009545 invasion Effects 0.000 description 5
239000000178 monomer Substances 0.000 description 5
239000000816 peptidomimetic Substances 0.000 description 5
238000012552 review Methods 0.000 description 5
108700024394 Exon Proteins 0.000 description 4
102100037362 Fibronectin Human genes 0.000 description 4
108010067306 Fibronectins Proteins 0.000 description 4
102000003688 G-Protein-Coupled Receptors Human genes 0.000 description 4
108090000045 G-Protein-Coupled Receptors Proteins 0.000 description 4
WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 4
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
102000003746 Insulin Receptor Human genes 0.000 description 4
108010001127 Insulin Receptor Proteins 0.000 description 4
COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 4
AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 4
102000002274 Matrix Metalloproteinases Human genes 0.000 description 4
108010000684 Matrix Metalloproteinases Proteins 0.000 description 4
241001465754 Metazoa Species 0.000 description 4
108700026244 Open Reading Frames Proteins 0.000 description 4
239000012472 biological sample Substances 0.000 description 4
238000004422 calculation algorithm Methods 0.000 description 4
230000003197 catalytic effect Effects 0.000 description 4
230000010261 cell growth Effects 0.000 description 4
230000005754 cellular signaling Effects 0.000 description 4
230000003247 decreasing effect Effects 0.000 description 4
239000005547 deoxyribonucleotide Substances 0.000 description 4
125000002637 deoxyribonucleotide group Chemical group 0.000 description 4
230000004069 differentiation Effects 0.000 description 4
230000013020 embryo development Effects 0.000 description 4
230000002255 enzymatic effect Effects 0.000 description 4
239000013604 expression vector Substances 0.000 description 4
238000003780 insertion Methods 0.000 description 4
230000037431 insertion Effects 0.000 description 4
230000009878 intermolecular interaction Effects 0.000 description 4
108020001756 ligand binding domains Proteins 0.000 description 4
230000009822 protein phosphorylation Effects 0.000 description 4
230000002797 proteolythic effect Effects 0.000 description 4
230000007115 recruitment Effects 0.000 description 4
230000000638 stimulation Effects 0.000 description 4
208000024891 symptom Diseases 0.000 description 4
238000003786 synthesis reaction Methods 0.000 description 4
230000002103 transcriptional effect Effects 0.000 description 4
102000007469 Actins Human genes 0.000 description 3
108010085238 Actins Proteins 0.000 description 3
101100314454 Caenorhabditis elegans tra-1 gene Proteins 0.000 description 3
101100481408 Danio rerio tie2 gene Proteins 0.000 description 3
102000002706 Discoidin Domain Receptors Human genes 0.000 description 3
108010043648 Discoidin Domain Receptors Proteins 0.000 description 3
201000009273 Endometriosis Diseases 0.000 description 3
108090000386 Fibroblast Growth Factor 1 Proteins 0.000 description 3
102100040896 Growth/differentiation factor 15 Human genes 0.000 description 3
HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 3
101001109792 Homo sapiens Pro-neuregulin-2, membrane-bound isoform Proteins 0.000 description 3
101000851007 Homo sapiens Vascular endothelial growth factor receptor 2 Proteins 0.000 description 3
108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 3
102000014429 Insulin-like growth factor Human genes 0.000 description 3
102100039688 Insulin-like growth factor 1 receptor Human genes 0.000 description 3
102100034343 Integrase Human genes 0.000 description 3
108091092195 Intron Proteins 0.000 description 3
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 3
102000005741 Metalloproteases Human genes 0.000 description 3
108010006035 Metalloproteases Proteins 0.000 description 3
101100481410 Mus musculus Tek gene Proteins 0.000 description 3
102100038895 Myc proto-oncogene protein Human genes 0.000 description 3
101710135898 Myc proto-oncogene protein Proteins 0.000 description 3
102000048238 Neuregulin-1 Human genes 0.000 description 3
102000035195 Peptidases Human genes 0.000 description 3
108091005804 Peptidases Proteins 0.000 description 3
108010038512 Platelet-Derived Growth Factor Proteins 0.000 description 3
102000010780 Platelet-Derived Growth Factor Human genes 0.000 description 3
108010092799 RNA-directed DNA polymerase Proteins 0.000 description 3
108091028664 Ribonucleotide Proteins 0.000 description 3
108091023040 Transcription factor Proteins 0.000 description 3
101710150448 Transcriptional regulator Myc Proteins 0.000 description 3
108010053099 Vascular Endothelial Growth Factor Receptor-2 Proteins 0.000 description 3
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 3
239000000556 agonist Substances 0.000 description 3
150000001412 amines Chemical class 0.000 description 3
239000000427 antigen Substances 0.000 description 3
108091007433 antigens Proteins 0.000 description 3
102000036639 antigens Human genes 0.000 description 3
230000006907 apoptotic process Effects 0.000 description 3
230000033228 biological regulation Effects 0.000 description 3
239000000872 buffer Substances 0.000 description 3
230000033077 cellular process Effects 0.000 description 3
238000003776 cleavage reaction Methods 0.000 description 3
230000007423 decrease Effects 0.000 description 3
238000009472 formulation Methods 0.000 description 3
229960002897 heparin Drugs 0.000 description 3
229920000669 heparin Polymers 0.000 description 3
238000009396 hybridization Methods 0.000 description 3
229940072221 immunoglobulins Drugs 0.000 description 3
238000000338 in vitro Methods 0.000 description 3
238000001727 in vivo Methods 0.000 description 3
230000006698 induction Effects 0.000 description 3
230000003834 intracellular effect Effects 0.000 description 3
230000008863 intramolecular interaction Effects 0.000 description 3
229920002521 macromolecule Polymers 0.000 description 3
108020004999 messenger RNA Proteins 0.000 description 3
238000003032 molecular docking Methods 0.000 description 3
210000003205 muscle Anatomy 0.000 description 3
239000013612 plasmid Substances 0.000 description 3
239000000047 product Substances 0.000 description 3
235000013930 proline Nutrition 0.000 description 3
125000001500 prolyl group Chemical group [H]N1C([H])(C(=O)[*])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 3
230000008707 rearrangement Effects 0.000 description 3
238000011084 recovery Methods 0.000 description 3
230000010076 replication Effects 0.000 description 3
238000011160 research Methods 0.000 description 3
230000000717 retained effect Effects 0.000 description 3
239000002336 ribonucleotide Substances 0.000 description 3
125000002652 ribonucleotide group Chemical group 0.000 description 3
230000007017 scission Effects 0.000 description 3
238000012216 screening Methods 0.000 description 3
238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 3
239000000243 solution Substances 0.000 description 3
238000007920 subcutaneous administration Methods 0.000 description 3
239000000758 substrate Substances 0.000 description 3
230000002123 temporal effect Effects 0.000 description 3
210000004881 tumor cell Anatomy 0.000 description 3
230000003827 upregulation Effects 0.000 description 3
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
WRGQSWVCFNIUNZ-GDCKJWNLSA-N 1-oleoyl-sn-glycerol 3-phosphate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)COP(O)(O)=O WRGQSWVCFNIUNZ-GDCKJWNLSA-N 0.000 description 2
208000023275 Autoimmune disease Diseases 0.000 description 2
241000894006 Bacteria Species 0.000 description 2
102100023995 Beta-nerve growth factor Human genes 0.000 description 2
102400001242 Betacellulin Human genes 0.000 description 2
101800001382 Betacellulin Proteins 0.000 description 2
208000031638 Body Weight Diseases 0.000 description 2
108091026890 Coding region Proteins 0.000 description 2
241001136239 Cymbidium hybrid cultivar Species 0.000 description 2
102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
108010014303 DNA-directed DNA polymerase Proteins 0.000 description 2
102000012545 EGF-like domains Human genes 0.000 description 2
108050002150 EGF-like domains Proteins 0.000 description 2
241000196324 Embryophyta Species 0.000 description 2
102000004190 Enzymes Human genes 0.000 description 2
108090000790 Enzymes Proteins 0.000 description 2
102000003971 Fibroblast Growth Factor 1 Human genes 0.000 description 2
102100035290 Fibroblast growth factor 13 Human genes 0.000 description 2
108090000379 Fibroblast growth factor 2 Proteins 0.000 description 2
102100027842 Fibroblast growth factor receptor 3 Human genes 0.000 description 2
101710182396 Fibroblast growth factor receptor 3 Proteins 0.000 description 2
102100021599 GTPase Era, mitochondrial Human genes 0.000 description 2
102000009465 Growth Factor Receptors Human genes 0.000 description 2
108010009202 Growth Factor Receptors Proteins 0.000 description 2
102100033067 Growth factor receptor-bound protein 2 Human genes 0.000 description 2
108091009389 Growth factor receptor-bound protein 2 Proteins 0.000 description 2
108090000100 Hepatocyte Growth Factor Proteins 0.000 description 2
102100021866 Hepatocyte growth factor Human genes 0.000 description 2
102100027619 Histidine-rich glycoprotein Human genes 0.000 description 2
101100065513 Homo sapiens ERAL1 gene Proteins 0.000 description 2
101000851181 Homo sapiens Epidermal growth factor receptor Proteins 0.000 description 2
101001081399 Homo sapiens Histidine-rich glycoprotein Proteins 0.000 description 2
101001034652 Homo sapiens Insulin-like growth factor 1 receptor Proteins 0.000 description 2
101000851030 Homo sapiens Vascular endothelial growth factor receptor 3 Proteins 0.000 description 2
QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 2
241000252067 Megalops atlanticus Species 0.000 description 2
241000699660 Mus musculus Species 0.000 description 2
108010025020 Nerve Growth Factor Proteins 0.000 description 2
101100168995 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) cyt-1 gene Proteins 0.000 description 2
108020004485 Nonsense Codon Proteins 0.000 description 2
208000000236 Prostatic Neoplasms Diseases 0.000 description 2
239000004365 Protease Substances 0.000 description 2
101000852966 Rattus norvegicus Interleukin-1 receptor-like 1 Proteins 0.000 description 2
238000012300 Sequence Analysis Methods 0.000 description 2
DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
208000037065 Subacute sclerosing leukoencephalitis Diseases 0.000 description 2
206010042297 Subacute sclerosing panencephalitis Diseases 0.000 description 2
108700005078 Synthetic Genes Proteins 0.000 description 2
AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 2
239000004473 Threonine Substances 0.000 description 2
IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
102000040945 Transcription factor Human genes 0.000 description 2
QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 2
ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
DRTQHJPVMGBUCF-XVFCMESISA-N Uridine Chemical group O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-XVFCMESISA-N 0.000 description 2
KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Chemical compound CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 2
108010053096 Vascular Endothelial Growth Factor Receptor-1 Proteins 0.000 description 2
230000001594 aberrant effect Effects 0.000 description 2
150000007513 acids Chemical class 0.000 description 2
230000003213 activating effect Effects 0.000 description 2
238000001042 affinity chromatography Methods 0.000 description 2
238000001261 affinity purification Methods 0.000 description 2
235000004279 alanine Nutrition 0.000 description 2
AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 description 2
230000003321 amplification Effects 0.000 description 2
238000004873 anchoring Methods 0.000 description 2
238000010171 animal model Methods 0.000 description 2
238000000137 annealing Methods 0.000 description 2
230000002424 anti-apoptotic effect Effects 0.000 description 2
230000001028 anti-proliverative effect Effects 0.000 description 2
230000003305 autocrine Effects 0.000 description 2
230000035578 autophosphorylation Effects 0.000 description 2
210000004369 blood Anatomy 0.000 description 2
239000008280 blood Substances 0.000 description 2
230000037396 body weight Effects 0.000 description 2
230000015556 catabolic process Effects 0.000 description 2
210000000170 cell membrane Anatomy 0.000 description 2
230000010307 cell transformation Effects 0.000 description 2
230000001413 cellular effect Effects 0.000 description 2
230000001684 chronic effect Effects 0.000 description 2
238000010367 cloning Methods 0.000 description 2
230000006552 constitutive activation Effects 0.000 description 2
210000000448 cultured tumor cell Anatomy 0.000 description 2
125000000151 cysteine group Chemical class N[C@@H](CS)C(=O)* 0.000 description 2
210000000805 cytoplasm Anatomy 0.000 description 2
230000000447 dimerizing effect Effects 0.000 description 2
208000037765 diseases and disorders Diseases 0.000 description 2
230000007783 downstream signaling Effects 0.000 description 2
210000002889 endothelial cell Anatomy 0.000 description 2
230000007613 environmental effect Effects 0.000 description 2
229940088598 enzyme Drugs 0.000 description 2
230000009422 growth inhibiting effect Effects 0.000 description 2
230000009036 growth inhibition Effects 0.000 description 2
230000007062 hydrolysis Effects 0.000 description 2
238000006460 hydrolysis reaction Methods 0.000 description 2
230000001939 inductive effect Effects 0.000 description 2
230000002401 inhibitory effect Effects 0.000 description 2
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
229940084651 iressa Drugs 0.000 description 2
238000005304 joining Methods 0.000 description 2
238000012423 maintenance Methods 0.000 description 2
239000003550 marker Substances 0.000 description 2
239000011159 matrix material Substances 0.000 description 2
239000012528 membrane Substances 0.000 description 2
210000004379 membrane Anatomy 0.000 description 2
101150023613 mev-1 gene Proteins 0.000 description 2
230000003278 mimic effect Effects 0.000 description 2
BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 2
229940053128 nerve growth factor Drugs 0.000 description 2
230000001537 neural effect Effects 0.000 description 2
238000003199 nucleic acid amplification method Methods 0.000 description 2
238000011580 nude mouse model Methods 0.000 description 2
230000007170 pathology Effects 0.000 description 2
230000004962 physiological condition Effects 0.000 description 2
230000008488 polyadenylation Effects 0.000 description 2
229920000642 polymer Polymers 0.000 description 2
238000006116 polymerization reaction Methods 0.000 description 2
238000012545 processing Methods 0.000 description 2
150000003148 prolines Chemical class 0.000 description 2
206010039073 rheumatoid arthritis Diseases 0.000 description 2
238000007423 screening assay Methods 0.000 description 2
210000002966 serum Anatomy 0.000 description 2
238000004904 shortening Methods 0.000 description 2
210000002460 smooth muscle Anatomy 0.000 description 2
235000019333 sodium laurylsulphate Nutrition 0.000 description 2
239000000725 suspension Substances 0.000 description 2
238000002560 therapeutic procedure Methods 0.000 description 2
230000005026 transcription initiation Effects 0.000 description 2
239000001226 triphosphate Substances 0.000 description 2
235000011178 triphosphate Nutrition 0.000 description 2
230000004614 tumor growth Effects 0.000 description 2
230000005751 tumor progression Effects 0.000 description 2
OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
235000002374 tyrosine Nutrition 0.000 description 2
230000006711 vascular endothelial growth factor production Effects 0.000 description 2
238000005406 washing Methods 0.000 description 2
230000029663 wound healing Effects 0.000 description 2
XUHRVZXFBWDCFB-QRTDKPMLSA-N (3R)-4-[[(3S,6S,9S,12R,15S,18R,21R,24R,27R,28R)-12-(3-amino-3-oxopropyl)-6-[(2S)-butan-2-yl]-3-(2-carboxyethyl)-18-(hydroxymethyl)-28-methyl-9,15,21,24-tetrakis(2-methylpropyl)-2,5,8,11,14,17,20,23,26-nonaoxo-1-oxa-4,7,10,13,16,19,22,25-octazacyclooctacos-27-yl]amino]-3-[[(2R)-2-[[(3S)-3-hydroxydecanoyl]amino]-4-methylpentanoyl]amino]-4-oxobutanoic acid Chemical compound CCCCCCC[C@H](O)CC(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H]1[C@@H](C)OC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CO)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC1=O)[C@@H](C)CC XUHRVZXFBWDCFB-QRTDKPMLSA-N 0.000 description 1
IEUUDEWWMRQUDS-UHFFFAOYSA-N (6-azaniumylidene-1,6-dimethoxyhexylidene)azanium;dichloride Chemical compound Cl.Cl.COC(=N)CCCCC(=N)OC IEUUDEWWMRQUDS-UHFFFAOYSA-N 0.000 description 1
BJHCYTJNPVGSBZ-YXSASFKJSA-N 1-[4-[6-amino-5-[(Z)-methoxyiminomethyl]pyrimidin-4-yl]oxy-2-chlorophenyl]-3-ethylurea Chemical compound CCNC(=O)Nc1ccc(Oc2ncnc(N)c2\C=N/OC)cc1Cl BJHCYTJNPVGSBZ-YXSASFKJSA-N 0.000 description 1
YKBGVTZYEHREMT-KVQBGUIXSA-N 2'-deoxyguanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](CO)O1 YKBGVTZYEHREMT-KVQBGUIXSA-N 0.000 description 1
YBBNVCVOACOHIG-UHFFFAOYSA-N 2,2-diamino-1,4-bis(4-azidophenyl)-3-butylbutane-1,4-dione Chemical compound C=1C=C(N=[N+]=[N-])C=CC=1C(=O)C(N)(N)C(CCCC)C(=O)C1=CC=C(N=[N+]=[N-])C=C1 YBBNVCVOACOHIG-UHFFFAOYSA-N 0.000 description 1
YVOOPGWEIRIUOX-UHFFFAOYSA-N 2-azanyl-3-sulfanyl-propanoic acid Chemical compound SCC(N)C(O)=O.SCC(N)C(O)=O YVOOPGWEIRIUOX-UHFFFAOYSA-N 0.000 description 1
QFVHZQCOUORWEI-UHFFFAOYSA-N 4-[(4-anilino-5-sulfonaphthalen-1-yl)diazenyl]-5-hydroxynaphthalene-2,7-disulfonic acid Chemical compound C=12C(O)=CC(S(O)(=O)=O)=CC2=CC(S(O)(=O)=O)=CC=1N=NC(C1=CC=CC(=C11)S(O)(=O)=O)=CC=C1NC1=CC=CC=C1 QFVHZQCOUORWEI-UHFFFAOYSA-N 0.000 description 1
102100026802 72 kDa type IV collagenase Human genes 0.000 description 1
101710151806 72 kDa type IV collagenase Proteins 0.000 description 1
102000015693 Actin Depolymerizing Factors Human genes 0.000 description 1
108010038798 Actin Depolymerizing Factors Proteins 0.000 description 1
ORILYTVJVMAKLC-UHFFFAOYSA-N Adamantane Natural products C1C(C2)CC3CC1CC2C3 ORILYTVJVMAKLC-UHFFFAOYSA-N 0.000 description 1
229920001817 Agar Polymers 0.000 description 1
101150044980 Akap1 gene Proteins 0.000 description 1
108700028369 Alleles Proteins 0.000 description 1
208000024827 Alzheimer disease Diseases 0.000 description 1
102000007299 Amphiregulin Human genes 0.000 description 1
102000009088 Angiopoietin-1 Human genes 0.000 description 1
108010048154 Angiopoietin-1 Proteins 0.000 description 1
108010063104 Apoptosis Regulatory Proteins Proteins 0.000 description 1
102000010565 Apoptosis Regulatory Proteins Human genes 0.000 description 1
239000004475 Arginine Substances 0.000 description 1
208000037260 Atherosclerotic Plaque Diseases 0.000 description 1
102100022717 Atypical chemokine receptor 1 Human genes 0.000 description 1
102100021663 Baculoviral IAP repeat-containing protein 5 Human genes 0.000 description 1
102100021277 Beta-secretase 2 Human genes 0.000 description 1
101710150190 Beta-secretase 2 Proteins 0.000 description 1
101710125089 Bindin Proteins 0.000 description 1
201000004569 Blindness Diseases 0.000 description 1
108090000715 Brain-derived neurotrophic factor Proteins 0.000 description 1
102000004219 Brain-derived neurotrophic factor Human genes 0.000 description 1
102100027207 CD27 antigen Human genes 0.000 description 1
101150013553 CD40 gene Proteins 0.000 description 1
102000000584 Calmodulin Human genes 0.000 description 1
108010041952 Calmodulin Proteins 0.000 description 1
201000009030 Carcinoma Diseases 0.000 description 1
108010076667 Caspases Proteins 0.000 description 1
102000011727 Caspases Human genes 0.000 description 1
ZEOWTGPWHLSLOG-UHFFFAOYSA-N Cc1ccc(cc1-c1ccc2c(n[nH]c2c1)-c1cnn(c1)C1CC1)C(=O)Nc1cccc(c1)C(F)(F)F Chemical compound Cc1ccc(cc1-c1ccc2c(n[nH]c2c1)-c1cnn(c1)C1CC1)C(=O)Nc1cccc(c1)C(F)(F)F ZEOWTGPWHLSLOG-UHFFFAOYSA-N 0.000 description 1
208000017667 Chronic Disease Diseases 0.000 description 1
206010009944 Colon cancer Diseases 0.000 description 1
208000001333 Colorectal Neoplasms Diseases 0.000 description 1
108020004635 Complementary DNA Proteins 0.000 description 1
208000011231 Crohn disease Diseases 0.000 description 1
241000195493 Cryptophyta Species 0.000 description 1
102000008130 Cyclic AMP-Dependent Protein Kinases Human genes 0.000 description 1
102000001189 Cyclic Peptides Human genes 0.000 description 1
108010069514 Cyclic Peptides Proteins 0.000 description 1
102000003910 Cyclin D Human genes 0.000 description 1
108090000259 Cyclin D Proteins 0.000 description 1
102000004127 Cytokines Human genes 0.000 description 1
108090000695 Cytokines Proteins 0.000 description 1
230000004544 DNA amplification Effects 0.000 description 1
230000006820 DNA synthesis Effects 0.000 description 1
230000004568 DNA-binding Effects 0.000 description 1
241000521299 Deinocerites cancer Species 0.000 description 1
208000002249 Diabetes Complications Diseases 0.000 description 1
206010012655 Diabetic complications Diseases 0.000 description 1
BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 1
101800001224 Disintegrin Proteins 0.000 description 1
101150097734 EPHB2 gene Proteins 0.000 description 1
101150029707 ERBB2 gene Proteins 0.000 description 1
108010049140 Endorphins Proteins 0.000 description 1
102100031968 Ephrin type-B receptor 2 Human genes 0.000 description 1
102100031982 Ephrin type-B receptor 3 Human genes 0.000 description 1
102220569198 Epidermal growth factor receptor_R98Q_mutation Human genes 0.000 description 1
102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
102000044168 Fibroblast Growth Factor Receptor Human genes 0.000 description 1
102100031706 Fibroblast growth factor 1 Human genes 0.000 description 1
102100028071 Fibroblast growth factor 7 Human genes 0.000 description 1
102100023593 Fibroblast growth factor receptor 1 Human genes 0.000 description 1
101710182386 Fibroblast growth factor receptor 1 Proteins 0.000 description 1
241000233866 Fungi Species 0.000 description 1
101100218425 Gallus gallus BCL2L1 gene Proteins 0.000 description 1
102100021022 Gastrin Human genes 0.000 description 1
102000004878 Gelsolin Human genes 0.000 description 1
108090001064 Gelsolin Proteins 0.000 description 1
206010064571 Gene mutation Diseases 0.000 description 1
239000004471 Glycine Substances 0.000 description 1
102000003886 Glycoproteins Human genes 0.000 description 1
108090000288 Glycoproteins Proteins 0.000 description 1
108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
102000004144 Green Fluorescent Proteins Human genes 0.000 description 1
HVLSXIKZNLPZJJ-TXZCQADKSA-N HA peptide Chemical compound C([C@@H](C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](C)C(O)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=C(O)C=C1 HVLSXIKZNLPZJJ-TXZCQADKSA-N 0.000 description 1
102100027618 Heme transporter HRG1 Human genes 0.000 description 1
101710198611 Heme transporter HRG1 Proteins 0.000 description 1
208000032843 Hemorrhage Diseases 0.000 description 1
102100035108 High affinity nerve growth factor receptor Human genes 0.000 description 1
101710091869 High affinity nerve growth factor receptor Proteins 0.000 description 1
101000678879 Homo sapiens Atypical chemokine receptor 1 Proteins 0.000 description 1
101000914511 Homo sapiens CD27 antigen Proteins 0.000 description 1
101001064458 Homo sapiens Ephrin type-B receptor 3 Proteins 0.000 description 1
101001060261 Homo sapiens Fibroblast growth factor 7 Proteins 0.000 description 1
101000840258 Homo sapiens Immunoglobulin J chain Proteins 0.000 description 1
101001103036 Homo sapiens Nuclear receptor ROR-alpha Proteins 0.000 description 1
101000619708 Homo sapiens Peroxiredoxin-6 Proteins 0.000 description 1
101001001487 Homo sapiens Phosphatidylinositol-glycan biosynthesis class F protein Proteins 0.000 description 1
101000595923 Homo sapiens Placenta growth factor Proteins 0.000 description 1
101001126417 Homo sapiens Platelet-derived growth factor receptor alpha Proteins 0.000 description 1
101000851176 Homo sapiens Pro-epidermal growth factor Proteins 0.000 description 1
101001109765 Homo sapiens Pro-neuregulin-3, membrane-bound isoform Proteins 0.000 description 1
101001109767 Homo sapiens Pro-neuregulin-4, membrane-bound isoform Proteins 0.000 description 1
101000801234 Homo sapiens Tumor necrosis factor receptor superfamily member 18 Proteins 0.000 description 1
101000851376 Homo sapiens Tumor necrosis factor receptor superfamily member 8 Proteins 0.000 description 1
101000851370 Homo sapiens Tumor necrosis factor receptor superfamily member 9 Proteins 0.000 description 1
101000753253 Homo sapiens Tyrosine-protein kinase receptor Tie-1 Proteins 0.000 description 1
101001103033 Homo sapiens Tyrosine-protein kinase transmembrane receptor ROR2 Proteins 0.000 description 1
102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 1
108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 1
102000018071 Immunoglobulin Fc Fragments Human genes 0.000 description 1
108010091135 Immunoglobulin Fc Fragments Proteins 0.000 description 1
102100029571 Immunoglobulin J chain Human genes 0.000 description 1
102000016844 Immunoglobulin-like domains Human genes 0.000 description 1
108050006430 Immunoglobulin-like domains Proteins 0.000 description 1
102000004877 Insulin Human genes 0.000 description 1
108090001061 Insulin Proteins 0.000 description 1
102100039137 Insulin receptor-related protein Human genes 0.000 description 1
101710184277 Insulin-like growth factor 1 receptor Proteins 0.000 description 1
150000008575 L-amino acids Chemical group 0.000 description 1
CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
239000005551 L01XE03 - Erlotinib Substances 0.000 description 1
URLZCHNOLZSCCA-VABKMULXSA-N Leu-enkephalin Chemical class C([C@@H](C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=CC=C1 URLZCHNOLZSCCA-VABKMULXSA-N 0.000 description 1
108060001084 Luciferase Proteins 0.000 description 1
239000005089 Luciferase Substances 0.000 description 1
206010058467 Lung neoplasm malignant Diseases 0.000 description 1
239000004472 Lysine Substances 0.000 description 1
241000124008 Mammalia Species 0.000 description 1
102100027754 Mast/stem cell growth factor receptor Kit Human genes 0.000 description 1
101710087603 Mast/stem cell growth factor receptor Kit Proteins 0.000 description 1
102100030412 Matrix metalloproteinase-9 Human genes 0.000 description 1
108010015302 Matrix metalloproteinase-9 Proteins 0.000 description 1
208000000172 Medulloblastoma Diseases 0.000 description 1
108010061593 Member 14 Tumor Necrosis Factor Receptors Proteins 0.000 description 1
206010027476 Metastases Diseases 0.000 description 1
DBTDEFJAFBUGPP-UHFFFAOYSA-N Methanethial Chemical compound S=C DBTDEFJAFBUGPP-UHFFFAOYSA-N 0.000 description 1
241001529936 Murinae Species 0.000 description 1
241000699666 Mus <mouse, genus> Species 0.000 description 1
125000000729 N-terminal amino-acid group Chemical group 0.000 description 1
102000003945 NF-kappa B Human genes 0.000 description 1
108010057466 NF-kappa B Proteins 0.000 description 1
206010061309 Neoplasm progression Diseases 0.000 description 1
206010029113 Neovascularisation Diseases 0.000 description 1
102000007339 Nerve Growth Factor Receptors Human genes 0.000 description 1
108010032605 Nerve Growth Factor Receptors Proteins 0.000 description 1
208000012902 Nervous system disease Diseases 0.000 description 1
208000025966 Neurological disease Diseases 0.000 description 1
108091005461 Nucleic proteins Proteins 0.000 description 1
108700020796 Oncogene Proteins 0.000 description 1
108010011536 PTEN Phosphohydrolase Proteins 0.000 description 1
102000014160 PTEN Phosphohydrolase Human genes 0.000 description 1
208000034038 Pathologic Neovascularization Diseases 0.000 description 1
108010067902 Peptide Library Proteins 0.000 description 1
102100022239 Peroxiredoxin-6 Human genes 0.000 description 1
102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
102100035194 Placenta growth factor Human genes 0.000 description 1
108010051742 Platelet-Derived Growth Factor beta Receptor Proteins 0.000 description 1
102100030485 Platelet-derived growth factor receptor alpha Human genes 0.000 description 1
ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
206010060862 Prostate cancer Diseases 0.000 description 1
102000012515 Protein kinase domains Human genes 0.000 description 1
108050002122 Protein kinase domains Proteins 0.000 description 1
241000485664 Protortonia cacti Species 0.000 description 1
102000004278 Receptor Protein-Tyrosine Kinases Human genes 0.000 description 1
108090000873 Receptor Protein-Tyrosine Kinases Proteins 0.000 description 1
101710100968 Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 description 1
108020004511 Recombinant DNA Proteins 0.000 description 1
102100033200 Rho guanine nucleotide exchange factor 7 Human genes 0.000 description 1
230000018199 S phase Effects 0.000 description 1
240000004808 Saccharomyces cerevisiae Species 0.000 description 1
244000000231 Sesamum indicum Species 0.000 description 1
BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
241000700584 Simplexvirus Species 0.000 description 1
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
108010017622 Somatomedin Receptors Proteins 0.000 description 1
102000004584 Somatomedin Receptors Human genes 0.000 description 1
108091081024 Start codon Proteins 0.000 description 1
108010002687 Survivin Proteins 0.000 description 1
210000001744 T-lymphocyte Anatomy 0.000 description 1
102100024547 Tensin-1 Human genes 0.000 description 1
108010088950 Tensins Proteins 0.000 description 1
102100023132 Transcription factor Jun Human genes 0.000 description 1
101710195626 Transcriptional activator protein Proteins 0.000 description 1
108020004566 Transfer RNA Proteins 0.000 description 1
102000009618 Transforming Growth Factors Human genes 0.000 description 1
108010009583 Transforming Growth Factors Proteins 0.000 description 1
102100031988 Tumor necrosis factor ligand superfamily member 6 Human genes 0.000 description 1
108050002568 Tumor necrosis factor ligand superfamily member 6 Proteins 0.000 description 1
102100028785 Tumor necrosis factor receptor superfamily member 14 Human genes 0.000 description 1
102100033728 Tumor necrosis factor receptor superfamily member 18 Human genes 0.000 description 1
102100033732 Tumor necrosis factor receptor superfamily member 1A Human genes 0.000 description 1
101710187743 Tumor necrosis factor receptor superfamily member 1A Proteins 0.000 description 1
102100033733 Tumor necrosis factor receptor superfamily member 1B Human genes 0.000 description 1
101710187830 Tumor necrosis factor receptor superfamily member 1B Proteins 0.000 description 1
102100022153 Tumor necrosis factor receptor superfamily member 4 Human genes 0.000 description 1
101710165473 Tumor necrosis factor receptor superfamily member 4 Proteins 0.000 description 1
102100040245 Tumor necrosis factor receptor superfamily member 5 Human genes 0.000 description 1
102100036857 Tumor necrosis factor receptor superfamily member 8 Human genes 0.000 description 1
102100036856 Tumor necrosis factor receptor superfamily member 9 Human genes 0.000 description 1
206010054094 Tumour necrosis Diseases 0.000 description 1
101150098329 Tyro3 gene Proteins 0.000 description 1
102100022007 Tyrosine-protein kinase receptor Tie-1 Human genes 0.000 description 1
102100039616 Tyrosine-protein kinase transmembrane receptor ROR2 Human genes 0.000 description 1
238000005411 Van der Waals force Methods 0.000 description 1
108010073923 Vascular Endothelial Growth Factor C Proteins 0.000 description 1
102000016548 Vascular Endothelial Growth Factor Receptor-1 Human genes 0.000 description 1
102100038232 Vascular endothelial growth factor C Human genes 0.000 description 1
102100033179 Vascular endothelial growth factor receptor 3 Human genes 0.000 description 1
230000005856 abnormality Effects 0.000 description 1
230000002378 acidificating effect Effects 0.000 description 1
238000007792 addition Methods 0.000 description 1
239000008272 agar Substances 0.000 description 1
150000001299 aldehydes Chemical class 0.000 description 1
230000001668 ameliorated effect Effects 0.000 description 1
150000001408 amides Chemical class 0.000 description 1
125000003277 amino group Chemical group 0.000 description 1
238000000540 analysis of variance Methods 0.000 description 1
239000003098 androgen Substances 0.000 description 1
208000036878 aneuploidy Diseases 0.000 description 1
231100001075 aneuploidy Toxicity 0.000 description 1
230000006427 angiogenic response Effects 0.000 description 1
230000001093 anti-cancer Effects 0.000 description 1
238000013459 approach Methods 0.000 description 1
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
235000009582 asparagine Nutrition 0.000 description 1
125000000613 asparagine group Chemical class N[C@@H](CC(N)=O)C(=O)* 0.000 description 1
235000003704 aspartic acid Nutrition 0.000 description 1
210000003719 b-lymphocyte Anatomy 0.000 description 1
DRTQHJPVMGBUCF-PSQAKQOGSA-N beta-L-uridine Natural products O[C@H]1[C@@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-PSQAKQOGSA-N 0.000 description 1
OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
230000001588 bifunctional effect Effects 0.000 description 1
239000011230 binding agent Substances 0.000 description 1
230000003851 biochemical process Effects 0.000 description 1
229960002685 biotin Drugs 0.000 description 1
235000020958 biotin Nutrition 0.000 description 1
239000011616 biotin Substances 0.000 description 1
230000036770 blood supply Effects 0.000 description 1
210000001124 body fluid Anatomy 0.000 description 1
239000010839 body fluid Substances 0.000 description 1
239000007975 buffered saline Substances 0.000 description 1
102220359937 c.221G>A Human genes 0.000 description 1
150000001720 carbohydrates Chemical class 0.000 description 1
235000014633 carbohydrates Nutrition 0.000 description 1
229910052799 carbon Inorganic materials 0.000 description 1
210000000845 cartilage Anatomy 0.000 description 1
238000000423 cell based assay Methods 0.000 description 1
238000004113 cell culture Methods 0.000 description 1
239000006143 cell culture medium Substances 0.000 description 1
230000009743 cell cycle entry Effects 0.000 description 1
230000030833 cell death Effects 0.000 description 1
230000032823 cell division Effects 0.000 description 1
230000004709 cell invasion Effects 0.000 description 1
230000032341 cell morphogenesis Effects 0.000 description 1
238000001516 cell proliferation assay Methods 0.000 description 1
230000008614 cellular interaction Effects 0.000 description 1
230000019522 cellular metabolic process Effects 0.000 description 1
230000036755 cellular response Effects 0.000 description 1
210000003169 central nervous system Anatomy 0.000 description 1
210000001175 cerebrospinal fluid Anatomy 0.000 description 1
210000003679 cervix uteri Anatomy 0.000 description 1
238000012412 chemical coupling Methods 0.000 description 1
238000004182 chemical digestion Methods 0.000 description 1
239000003153 chemical reaction reagent Substances 0.000 description 1
238000002512 chemotherapy Methods 0.000 description 1
238000004587 chromatography analysis Methods 0.000 description 1
230000002759 chromosomal effect Effects 0.000 description 1
210000000349 chromosome Anatomy 0.000 description 1
208000037976 chronic inflammation Diseases 0.000 description 1
230000006020 chronic inflammation Effects 0.000 description 1
DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 description 1
229960004316 cisplatin Drugs 0.000 description 1
208000029742 colonic neoplasm Diseases 0.000 description 1
238000002648 combination therapy Methods 0.000 description 1
238000004590 computer program Methods 0.000 description 1
238000011109 contamination Methods 0.000 description 1
239000010949 copper Substances 0.000 description 1
230000001054 cortical effect Effects 0.000 description 1
230000008878 coupling Effects 0.000 description 1
239000007822 coupling agent Substances 0.000 description 1
238000010168 coupling process Methods 0.000 description 1
238000005859 coupling reaction Methods 0.000 description 1
238000004132 cross linking Methods 0.000 description 1
239000013078 crystal Substances 0.000 description 1
230000001186 cumulative effect Effects 0.000 description 1
210000004292 cytoskeleton Anatomy 0.000 description 1
230000002950 deficient Effects 0.000 description 1
238000006731 degradation reaction Methods 0.000 description 1
230000030609 dephosphorylation Effects 0.000 description 1
238000006209 dephosphorylation reaction Methods 0.000 description 1
238000013461 design Methods 0.000 description 1
125000005442 diisocyanate group Chemical group 0.000 description 1
238000009826 distribution Methods 0.000 description 1
ZWIBGKZDAWNIFC-UHFFFAOYSA-N disuccinimidyl suberate Chemical compound O=C1CCC(=O)N1OC(=O)CCCCCCC(=O)ON1C(=O)CCC1=O ZWIBGKZDAWNIFC-UHFFFAOYSA-N 0.000 description 1
230000006334 disulfide bridging Effects 0.000 description 1
238000013104 docking experiment Methods 0.000 description 1
238000009509 drug development Methods 0.000 description 1
230000008482 dysregulation Effects 0.000 description 1
230000009881 electrostatic interaction Effects 0.000 description 1
230000008030 elimination Effects 0.000 description 1
238000003379 elimination reaction Methods 0.000 description 1
230000012202 endocytosis Effects 0.000 description 1
210000002472 endoplasmic reticulum Anatomy 0.000 description 1
102000012803 ephrin Human genes 0.000 description 1
108060002566 ephrin Proteins 0.000 description 1
AAKJLRGGTJKAMG-UHFFFAOYSA-N erlotinib Chemical compound C=12C=C(OCCOC)C(OCCOC)=CC2=NC=NC=1NC1=CC=CC(C#C)=C1 AAKJLRGGTJKAMG-UHFFFAOYSA-N 0.000 description 1
229960001433 erlotinib Drugs 0.000 description 1
210000003238 esophagus Anatomy 0.000 description 1
150000002148 esters Chemical class 0.000 description 1
210000003527 eukaryotic cell Anatomy 0.000 description 1
238000011156 evaluation Methods 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
210000002744 extracellular matrix Anatomy 0.000 description 1
239000000284 extract Substances 0.000 description 1
229910052731 fluorine Inorganic materials 0.000 description 1
150000002222 fluorine compounds Chemical class 0.000 description 1
230000005714 functional activity Effects 0.000 description 1
206010017758 gastric cancer Diseases 0.000 description 1
208000010749 gastric carcinoma Diseases 0.000 description 1
239000000499 gel Substances 0.000 description 1
230000002068 genetic effect Effects 0.000 description 1
235000013922 glutamic acid Nutrition 0.000 description 1
239000004220 glutamic acid Substances 0.000 description 1
ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
230000013595 glycosylation Effects 0.000 description 1
238000006206 glycosylation reaction Methods 0.000 description 1
210000002288 golgi apparatus Anatomy 0.000 description 1
239000005090 green fluorescent protein Substances 0.000 description 1
244000144980 herd Species 0.000 description 1
HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
102000045108 human EGFR Human genes 0.000 description 1
210000004754 hybrid cell Anatomy 0.000 description 1
125000001165 hydrophobic group Chemical group 0.000 description 1
125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
150000002463 imidates Chemical class 0.000 description 1
230000008102 immune modulation Effects 0.000 description 1
238000000126 in silico method Methods 0.000 description 1
238000007850 in situ PCR Methods 0.000 description 1
238000005462 in vivo assay Methods 0.000 description 1
239000000411 inducer Substances 0.000 description 1
210000004969 inflammatory cell Anatomy 0.000 description 1
230000028709 inflammatory response Effects 0.000 description 1
206010022000 influenza Diseases 0.000 description 1
230000000977 initiatory effect Effects 0.000 description 1
229940125396 insulin Drugs 0.000 description 1
108010054372 insulin receptor-related receptor Proteins 0.000 description 1
108010044426 integrins Proteins 0.000 description 1
102000006495 integrins Human genes 0.000 description 1
230000031146 intracellular signal transduction Effects 0.000 description 1
230000004068 intracellular signaling Effects 0.000 description 1
230000010189 intracellular transport Effects 0.000 description 1
238000007912 intraperitoneal administration Methods 0.000 description 1
230000006623 intrinsic pathway Effects 0.000 description 1
238000005342 ion exchange Methods 0.000 description 1
210000003734 kidney Anatomy 0.000 description 1
208000032839 leukemia Diseases 0.000 description 1
238000007854 ligation-mediated PCR Methods 0.000 description 1
230000000670 limiting effect Effects 0.000 description 1
239000007788 liquid Substances 0.000 description 1
230000004807 localization Effects 0.000 description 1
201000005202 lung cancer Diseases 0.000 description 1
210000005265 lung cell Anatomy 0.000 description 1
208000020816 lung neoplasm Diseases 0.000 description 1
210000002751 lymph Anatomy 0.000 description 1
210000001165 lymph node Anatomy 0.000 description 1
238000007403 mPCR Methods 0.000 description 1
208000002780 macular degeneration Diseases 0.000 description 1
230000003211 malignant effect Effects 0.000 description 1
210000004962 mammalian cell Anatomy 0.000 description 1
210000001161 mammalian embryo Anatomy 0.000 description 1
239000000463 material Substances 0.000 description 1
238000005259 measurement Methods 0.000 description 1
239000002609 medium Substances 0.000 description 1
230000009401 metastasis Effects 0.000 description 1
125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 1
230000004001 molecular interaction Effects 0.000 description 1
238000000302 molecular modelling Methods 0.000 description 1
229960005181 morphine Drugs 0.000 description 1
230000011234 negative regulation of signal transduction Effects 0.000 description 1
GVUGOAYIVIDWIO-UFWWTJHBSA-N nepidermin Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C(C)C)C(C)C)C1=CC=C(O)C=C1 GVUGOAYIVIDWIO-UFWWTJHBSA-N 0.000 description 1
230000000926 neurological effect Effects 0.000 description 1
208000018360 neuromuscular disease Diseases 0.000 description 1
208000002154 non-small cell lung carcinoma Diseases 0.000 description 1
238000001216 nucleic acid method Methods 0.000 description 1
210000004940 nucleus Anatomy 0.000 description 1
238000006384 oligomerization reaction Methods 0.000 description 1
238000001543 one-way ANOVA Methods 0.000 description 1
210000000056 organ Anatomy 0.000 description 1
210000001672 ovary Anatomy 0.000 description 1
238000012261 overproduction Methods 0.000 description 1
210000000496 pancreas Anatomy 0.000 description 1
230000003076 paracrine Effects 0.000 description 1
210000004738 parenchymal cell Anatomy 0.000 description 1
239000006072 paste Substances 0.000 description 1
230000009963 pathologic angiogenesis Effects 0.000 description 1
230000001575 pathological effect Effects 0.000 description 1
230000006320 pegylation Effects 0.000 description 1
210000001428 peripheral nervous system Anatomy 0.000 description 1
210000001322 periplasm Anatomy 0.000 description 1
230000002085 persistent effect Effects 0.000 description 1
230000004526 pharmaceutical effect Effects 0.000 description 1
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
DCWXELXMIBXGTH-QMMMGPOBSA-N phosphonotyrosine Chemical group OC(=O)[C@@H](N)CC1=CC=C(OP(O)(O)=O)C=C1 DCWXELXMIBXGTH-QMMMGPOBSA-N 0.000 description 1
238000003566 phosphorylation assay Methods 0.000 description 1
210000002381 plasma Anatomy 0.000 description 1
108010017843 platelet-derived growth factor A Proteins 0.000 description 1
239000012985 polymerization agent Substances 0.000 description 1
238000010837 poor prognosis Methods 0.000 description 1
230000016833 positive regulation of signal transduction Effects 0.000 description 1
230000029279 positive regulation of transcription, DNA-dependent Effects 0.000 description 1
230000001323 posttranslational effect Effects 0.000 description 1
239000000843 powder Substances 0.000 description 1
238000001556 precipitation Methods 0.000 description 1
238000002360 preparation method Methods 0.000 description 1
108010012766 preprogastrin Proteins 0.000 description 1
230000001023 pro-angiogenic effect Effects 0.000 description 1
230000000861 pro-apoptotic effect Effects 0.000 description 1
230000009465 prokaryotic expression Effects 0.000 description 1
230000002035 prolonged effect Effects 0.000 description 1
230000001737 promoting effect Effects 0.000 description 1
235000019833 protease Nutrition 0.000 description 1
235000019419 proteases Nutrition 0.000 description 1
230000006337 proteolytic cleavage Effects 0.000 description 1
210000001243 pseudopodia Anatomy 0.000 description 1
JWVCLYRUEFBMGU-UHFFFAOYSA-N quinazoline Chemical compound N1=CN=CC2=CC=CC=C21 JWVCLYRUEFBMGU-UHFFFAOYSA-N 0.000 description 1
230000005855 radiation Effects 0.000 description 1
230000002285 radioactive effect Effects 0.000 description 1
238000010188 recombinant method Methods 0.000 description 1
238000004064 recycling Methods 0.000 description 1
230000009467 reduction Effects 0.000 description 1
230000002829 reductive effect Effects 0.000 description 1
230000012760 regulation of cell migration Effects 0.000 description 1
230000025053 regulation of cell proliferation Effects 0.000 description 1
230000009711 regulatory function Effects 0.000 description 1
239000003488 releasing hormone Substances 0.000 description 1
238000004007 reversed phase HPLC Methods 0.000 description 1
108020004418 ribosomal RNA Proteins 0.000 description 1
230000022932 ruffle assembly Effects 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
201000000980 schizophrenia Diseases 0.000 description 1
230000003248 secreting effect Effects 0.000 description 1
230000035945 sensitivity Effects 0.000 description 1
230000009919 sequestration Effects 0.000 description 1
125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 description 1
229910052709 silver Inorganic materials 0.000 description 1
239000004332 silver Substances 0.000 description 1
238000001542 size-exclusion chromatography Methods 0.000 description 1
210000003491 skin Anatomy 0.000 description 1
208000000649 small cell carcinoma Diseases 0.000 description 1
239000002689 soil Substances 0.000 description 1
125000006850 spacer group Chemical group 0.000 description 1
230000006641 stabilisation Effects 0.000 description 1
238000011105 stabilization Methods 0.000 description 1
230000000087 stabilizing effect Effects 0.000 description 1
108020003113 steroid hormone receptors Proteins 0.000 description 1
102000005969 steroid hormone receptors Human genes 0.000 description 1
201000000498 stomach carcinoma Diseases 0.000 description 1
230000008093 supporting effect Effects 0.000 description 1
238000001356 surgical procedure Methods 0.000 description 1
210000004243 sweat Anatomy 0.000 description 1
210000001179 synovial fluid Anatomy 0.000 description 1
238000010189 synthetic method Methods 0.000 description 1
229940124597 therapeutic agent Drugs 0.000 description 1
229940124598 therapeutic candidate Drugs 0.000 description 1
125000003396 thiol group Chemical group [H]S* 0.000 description 1
CNHYKKNIIGEXAY-UHFFFAOYSA-N thiolan-2-imine Chemical compound N=C1CCCS1 CNHYKKNIIGEXAY-UHFFFAOYSA-N 0.000 description 1
RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical compound [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 description 1
231100000041 toxicology testing Toxicity 0.000 description 1
238000001890 transfection Methods 0.000 description 1
238000012546 transfer Methods 0.000 description 1
230000009466 transformation Effects 0.000 description 1
230000001131 transforming effect Effects 0.000 description 1
230000007704 transition Effects 0.000 description 1
230000014621 translational initiation Effects 0.000 description 1
102000035160 transmembrane proteins Human genes 0.000 description 1
108091005703 transmembrane proteins Proteins 0.000 description 1
102000027257 transmembrane receptors Human genes 0.000 description 1
108091008578 transmembrane receptors Proteins 0.000 description 1
230000032258 transport Effects 0.000 description 1
239000013638 trimer Substances 0.000 description 1
230000005748 tumor development Effects 0.000 description 1
208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 description 1
238000007492 two-way ANOVA Methods 0.000 description 1
238000011144 upstream manufacturing Methods 0.000 description 1
229940035893 uracil Drugs 0.000 description 1
DRTQHJPVMGBUCF-UHFFFAOYSA-N uracil arabinoside Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UHFFFAOYSA-N 0.000 description 1
229940045145 uridine Drugs 0.000 description 1
210000002700 urine Anatomy 0.000 description 1
230000002792 vascular Effects 0.000 description 1
210000003556 vascular endothelial cell Anatomy 0.000 description 1
230000007998 vessel formation Effects 0.000 description 1
OGWKCGZFUXNPDA-XQKSVPLYSA-N vincristine Chemical compound C([N@]1C[C@@H](C[C@]2(C(=O)OC)C=3C(=CC4=C([C@]56[C@H]([C@@]([C@H](OC(C)=O)[C@]7(CC)C=CCN([C@H]67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)C[C@@](C1)(O)CC)CC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-XQKSVPLYSA-N 0.000 description 1
230000003612 virological effect Effects 0.000 description 1
230000000007 visual effect Effects 0.000 description 1
238000012800 visualization Methods 0.000 description 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
230000037314 wound repair Effects 0.000 description 1